Radiopharm Theranostics Limited American Depositary Shares (RADX)

Radiopharm Theranostics Limited American Depositary Shares (RADX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $15.8M; returns 1 day +6.3%, 1 week -1.9%, 1 year -81.8%.

Radiopharm Theranostics Limited is a clinical-stage biopharmaceutical company focused on the development of a diverse pipeline of radiopharmaceutical products for oncology, utilizing a 'theranostic' approach that combines diagnostic imaging and targeted therapeutic agents.

Groups RADX belongs to

• Biopharmaceutical
• Clinical Stage Biopharma
• Oncology
• Cancer Therapeutics
• Healthcare
• Biotechnology
• Life Sciences
• Precision Medicine
• R&D
• Antibody Therapeutics
• Health Diagnostics and Imaging

RADX financial model: income statement, cash flow and balance sheet